Контакты | НИАРМЕДИК ПЛЮС

     
 

Milestones

  • Establishment of NEARMEDIC.
  • Development and start of production of a wide range of products for diagnostics.
  • Establishment of NEARMEDIC medical service center and Central clinical laboratory NEARMEDIC.
    Launch of the Department of laboratory equipment.
    Development of new original class of antiviral drugs.
  • Launch of the diagnostic kits production facility compliant with GMP standards.
  • Establishment and expansion of NEARMEDIC’s mutual cooperation with the largest international companies – world leaders in diagnostic products and laboratory equipment
  • Launch of pharmaceutical production facility and registration of novel antiviral drug Kagocel®
  • Growth and expansion of NEARMEDIC medical diagnostic and laboratory hardware business
  • Growth and defelopment of NEARMEDIC pharmaceutical business
  • Expansion and improvement of NEARMEDIC medical and laboratory services business

1989

 

Establishment of NEARMEDIC.

The company was founded by the group of leading researchers on the territory of the Gamaleya Institute, a research institute with a respected international reputation for epidemiology and microbiology, of the Russian Academy of Medical Sciences. (The Gamaleya Institute is an analogue of the Pasteur Institute in Paris and Robert Koch Institute in Berlin). NEARMEDIC was aimed at the introduction of innovative R&D results into broad medical practice with the main area of application being laboratory diagnostics of infectious diseases.

1990-1995

 

Development and start of production of a wide range of products for diagnostics.

 

1990

NEARMEDIC launched production and started active introduction into medical practice of its first domestic innovative diagnostic test-kit “ChlaMonoScreen” based on monoclonal antibodies for diagnostics of Chlamydia infection using immunofluorescence technique.

1991-1995

Development and start of production of a wide range of products for diagnostics of venereal diseases and viral hepatitis and other infections; and entered the market with these diagnostic products (over 70 types of diagnostic kits).

Start-up of NEARMEDIC Training Center for the provision of modern laboratory diagnostics training for the health care professionals.

1996

 

Establishment of NEARMEDIC medical service center and Central clinical laboratory NEARMEDIC.
Launch of the Department of laboratory equipment.
Development of new original class of antiviral drugs.

Development of a new original class of antiviral biotechnology – a mucosal surface acting inducer of interferon, and the leading product Kagocel®.

Launch of the department for microbiological laboratory equipment for complex supply of modern laboratory instruments and technique to clinical laboratories.

Establishment of NEARMEDIC medical service center and NEARMEDIC clinical laboratory at the Gamaleya Institute.

1997-1998

 

Launch of the diagnostic kits production facility compliant with GMP standards.

 

1997

Start of cooperation with the leading international diagnostic company Murex Biotech (U.K.) for producing licensed test systems for detection of antibodies to hepatitis C virus.

1998

NEARMEDIC launched of the first diagnostic kits production facility compliant with GMP standards in Russia.

Start-up the NEARMEDIC production of the 4th-generation diagnostic kit for the detection of antibodies to hepatitis C virus under a license agreement with Murex Biotech (U.K.).

NEARMEDIC launched the production of new generation highly standardized test-kits for syphilis diagnostics “Lues TPHA test” and “Lues RPR test”.

1999-2002

 

Establishment and expansion of NEARMEDIC’s mutual cooperation with the largest international companies – world leaders in diagnostic products and laboratory equipment

Establishment and expansion of NEARMEDIC's mutual cooperation with the largest international companies – world leaders in diagnostic products and laboratory equipment including: Abbott Diagnostics (USA), Abbott Murex (U.K.), Dainabot (Japan), Innogenetics (Belgium), Tecan (Switzerland), Don Whitley Scientific (U.K.), Faster (Italy), Europrobe (France), AES Laboratoire (France), Varian (USA), Binder (Germany), Bio Merieux (France), Beckman Coulter (USA), Miele (Germany) and others to propose and introduce to the Russian market the innovative diagnostic methods, products and modern diagnostic instruments for the needs of medical laboratories.

In 2002, NEARMEDIC started the production under a license agreement with Abbott Diagnostics (USA) of EIA diagnostic kits for simultaneous detection of antibodies to HIV and p24 antigen of HIV used for screening at AIDS centers and blood banks. The production was audited for compliance with GMP standards by Abbott experts.

2003

 

Launch of pharmaceutical production facility and registration of novel antiviral drug Kagocel®

Registration in Russia of Kagocel®, an original pharmaceutical product based on NEARMEDIC's novel interferon induction biotechnology, as an oral antiviral drug, with the indications for the treatment of flu, ARVI and herpes virus infection in adults.

2004-2009

 

Growth and expansion of NEARMEDIC medical diagnostic and laboratory hardware business

 

2004

Launch of production of HIV and viral hepatitis C confirming tests with the NEARMEDIC trademark under license from Innogenetics (Belgium)

2005

The commencement of the NEARMEDIC mutual collaboration with Abbott Molecular (USA) and Celera Diagnostic (USA) on the registration in Russia of molecular diagnostics product line RealTime® of Abbott Molecular including reagents and real time PCR equipment for automated quantitative detection of HIV-1, hepatites B and C and CMV viral load, quality detection of Chlamydia trachomatis and Neisseria gonorrhoeae in clinical samples as well as the automated ViroSeq®HIV-1 Genotyping System intended for use in detecting HIV genomic mutations that confer resistance to antiretroviral drugs; supporting the monitoring and treatment of HIV infection.

NEARMEDIC registered in Russia the immuno assay “INNO-LIA Syphilis Score” (Innogenetics, Belgium) for confirmatory reference diagnostics of syphilis.

2006

NEARMEDIC and TOKAD developed and registered in Russia an automated diagnostic complex “Criterium-2” for quantitative evaluation of TPHA reaction results in syphilis serodiagnostics for diagnostic kits “Lues TPHA test”.

NEARMEDIC became the established supplier within the National Priority Project “Health”. NEARMEDIC supplied all Russian AIDS centers with diagnostic kits for the confirmation of HIV seroconversion (LIA HIV-1/2); EIA kits for simultaneous detection of HIV antibodies and HIV antigen in HIV screening (HIV-1,2 Ag/Ab COMBOTEST); Abbott automated equipment m2000rt, m2000sp and kits (RealTime HIV-1) for the quantitative detection of HIV viral load; and ViroSeq®HIV-1 Genotyping System for ABI 3100 Avant genetic analyzers for detecting HIV genomic mutations that confer resistance to antiretroviral drugs.

2007

p> NEARMEDIC and TOCAD developed and registered in Russia an automated diagnostic complex “Criteruim-1”, for quantitative assessment of T-cell immunity

On the request of ROSPOTREBNADZOR (Russian Federal Surveillance Service on the Protection of Consumers and Human Welfare) NEARMEDIC has supplied and registered in Russia three new diagnostic kits for rapid differential diagnostic of Legionella pneumophila and S.pneumonia infection by the detection of the germ’s antigen in urine (produced by Binax / Inverness Professional Medical Diagnostics, USA). The diagnostic kits were used to diagnose Legionella epidemic outbreak in V.Pyshma, Sverdlovsk region in July, 2007.

2005-2009

 

Growth and defelopment of NEARMEDIC pharmaceutical business

 

2005

Kagocel® was listed by the Russian Ministry of Health and Social Development as a non-prescription OTC-drug in Russia.

Registration and sale of Kagocel® in Ukraine.

2007

Start-up of NEARMEDIC PHARMA Division for the coordination of promotion efforts of pharmaceutical preparations.

NEARMEDIC PHARMA Division expanded its network of medical representatives with the offices in St.-Petersburg, Ekaterinburg, Kazan, Krasnodar, Nizhniy Novgorod, Novosibirsk, Perm, Omsk, Rostov-on-Don, Ufa, Minsk (Byelorussia) and distributor office of AlexPHARM, Kiev, Ukraine.

Development and registration in collaboration with BioPHARMAHOLDING the innovative biological collagenic implants, called COLLOST®.

2007

NEARMEDIC registered Kagocel® with expanded indications for influenza and ARVI treatment for children of 6 years and older.

Kagocel® was registered in Byelorussia.

2009

NEARMEDIC registered prophylaxis indications for Kagocel® for influenza and ARVI for children of 6 years and older.

Experimental studies were performed at Influenza Research Institute (St.-Petersburg) and D.I. Ivanovskiy Virology Research Institute (Moscow) of the Russian Academy of Medical Sciences that proved that Kagocel® has a high virus-inhibiting effect on isolates of pandemic influenza virus A(H1N1) inoculated into cell cultures and that drug effectively protects cells from infection by highly virulent influenza virus strains.

Russian Ministry of Health and Social Development included Kagocel® into the provisional guidelines “Treatment and prevention of pandemic influenza virus A(H1N1) infection in adults”.

Kagocel® was included into the List of essential drugs approved by the Order signed by the Chairman of the Government of the Russian Federation in December of 2009. Kagocel® was also included in the system of state procurement in the Russian Federation.

Distribution in Russia and CIS of COLLOST®, an innovative medical product used in surgery, traumatology, dentistry, and medical aesthetics, produced from high-purity native non-reconstructed 1 type bovine collagen. The product was distributed under the agreement with BioPHARMAHOLDING, a company acquired by NEARMEDIC PLUS in 2010 (see Web-site: www.collost.ru).

2006-2009

 

Expansion and improvement of NEARMEDIC medical and laboratory services business

 

2006

Expansion and re-equipment of the clinical laboratory of NEARMEDIC with automated immunological, biochemical and hematological analyzers.

2009

Acquisition by NEARMEDIC the National Medical Service alinic – an multi-field clinic with in-patient service located in Moscow.

Start-up of NEARMEDIC Medical services Division for the management and coordination of promotional efforts.

Expansion of the NEARMEDIC clinics chain in Moscow to two specialized out-patient clinics, one multi-field clinic and two analysis collection offices and at home analyses collection service.

NEARMEDIC was founded 20 years ago in 1989, by the group of like-minded researchers of the Gamaleya Research Institute of Epidemiology and Microbiology of the USSR Academy of Medical Sciences. The objective of the new enterprise was to collect their research and development know-how and apply it to the introduction of products and services in diagnostics & pharmaceuticals for prevention and treatment of different infectious diseases.

The establishment and expansion of a diagnostic business allowed NEARMEDIC to support innovative and applied research in medical infectology and immunology during a period when state financing of science was at a low level.

The foundation of the NEARMEDIC success story is reliable partnerships, high quality services and a scientific attitude in all aspects of product and service development and business. NEARMEDIC is distinguished by a close liaison with academic and research communities, extensive collaboration with state and private medical institutions of Russia, long-term international partnership with the world leading companies including manufacturers of advanced technologies, reagents and equipment for clinical laboratory diagnostics.

NEARMEDIC today is a Russian pharmaceutical, biotechnological and medical diversified company. It is a supplier of modern diagnostic products (self-manufactured as well as produced by other Russian and international companies), develops and manufactures novel pharmaceutical products, supplies medical laboratory diagnostic equipment to the Russian and CIS medical markets; and also provides medical and clinical laboratory services to patients through a chain of private clinics supported by the NEARMEDIC central clinical laboratory.